Cullinan Therapeutics, Inc. - COM (CGEM)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / COM
Number of holders
93
Total Shares
37M
Shares change
-551K
Total reported value, excl. options
$475M
Value change
-$7.06M
Put/Call ratio
0
Number of buys
55
Number of sells
-34
Price
$12.82
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.